Immunovant Inc
XNAS:IMVT 9:32:52 AM EDT
Immunovant Inc Stock, XNAS:IMVT
320 West 37th Street, 6th floor, New York, New York 10018
United States of America
Phone: +1.917.580.3099
Number of Employees: 207
Description
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.